SG3 Management, LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2021. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q4 2022$212,443
-28.5%
34,100
+143.6%
0.03%
+172.7%
Q2 2021$297,000
-86.5%
14,000
-67.4%
0.01%
-92.8%
Q2 2020$2,206,000
+159.2%
43,000
+59.3%
0.15%
+34.2%
Q1 2020$851,00027,0000.11%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2021
NameSharesValueWeighting ↓
Meditor Group Ltd 3,791,300$3,715,4744.82%
Two Seas Capital LP 7,672,170$7,518,7271.51%
Parkman Healthcare Partners LLC 1,997,071$1,957,1300.36%
Monaco Asset Management SAM 1,171,779$1,148,3430.34%
TANG CAPITAL MANAGEMENT LLC 1,850,000$1,813,0000.26%
Ikarian Capital, LLC 1,737,636$1,702,8830.20%
PLATINUM INVESTMENT MANAGEMENT LTD 3,189,517$3,125,7270.12%
GSA CAPITAL PARTNERS LLP 1,116,655$1,0940.09%
XTX Topco Ltd 519,129$508,7460.09%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 60,000$58,8000.08%
View complete list of ESPERION THERAPEUTICS INC NE shareholders